Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hope S Rugo

107PUBLICATIONS
531CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEconomic models and forecastingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (107)

Sort by Publication Date:
|Jul 10, 2026
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|Jun 30, 2026
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio‑Oncology Society (IC‑OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 29, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 28, 2026
Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.

|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Mar 30, 2026
OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer.

Hope S Rugo, T J Pluard, P Sharma

Pageof 18

Frequent Collaborators

15 joint publications

Sara M Tolaney

13 joint publications

Laura Van't Veer

13 joint publications

Javier Cortes

11 joint publications

Laura J Esserman

11 joint publications

Aditya Bardia

10 joint publications

Angela M DeMichele

10 joint publications

Sara Hurvitz

9 joint publications

Rita Nanda

8 joint publications

Lamorna Brown-Swigart

8 joint publications

Gillian L Hirst

Frequent Collaborators

15 joint publications

Sara M Tolaney

13 joint publications

Laura Van't Veer

13 joint publications

Javier Cortes

11 joint publications

Laura J Esserman